Insider Trades23 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Sell | TCMD | Elaine M. Birkemeyer | CHIEF FINANCIAL OFFICER | 4,631 | $24.49 | $648.3M | -23.91% | +205.26% | $113.4K | -3.43% | — | Sell Now |
| Feb 24, 2026 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 6,246 | $28.94 | $648.3M | -23.91% | +205.26% | $180.8K | -7.03% | — | Sell Now |
| Feb 24, 2026 | Sell | TCMD | Elaine M. Birkemeyer | CHIEF FINANCIAL OFFICER | 7,701 | $28.94 | $648.3M | -23.91% | +205.26% | $222.9K | -5.40% | — | Sell Now |
| Feb 24, 2026 | Sell | TCMD | Sheri Louise Dodd | Chief Executive Officer | 10,993 | $28.94 | $648.3M | -23.91% | +205.26% | $318.1K | -4.31% | — | Sell Now |
| Feb 23, 2026 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 4,439 | $28.30 | $648.3M | -23.91% | +205.26% | $125.6K | -2.44% | — | Sell Now |
| Feb 23, 2026 | Sell | TCMD | Elaine M. Birkemeyer | CHIEF FINANCIAL OFFICER | 5,518 | $28.30 | $648.3M | -23.91% | +205.26% | $156.1K | -1.90% | — | Sell Now |
| Feb 23, 2026 | Sell | TCMD | Sheri Louise Dodd | Chief Executive Officer | 15,240 | $28.30 | $648.3M | -23.91% | +205.26% | $431.2K | -2.90% | — | Sell Now |
| Jan 2, 2026 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 5,139 | $28.85 | $648.3M | -23.91% | +205.26% | $148.3K | -6.63% | 10b5-1 | Sell Now |
| Aug 8, 2025 | Sell | TCMD | Sheri Louise Dodd | Chief Executive Officer | 7,762 | $12.36 | $648.3M | -23.91% | +205.26% | $95.9K | -4.28% | — | Sell Now |
| May 12, 2025 | Sell | TCMD | Elaine M. Birkemeyer | Chief Financial Officer | 2,921 | $9.94 | $648.3M | -23.91% | +205.26% | $29.0K | -2.86% | 10b5-1 | Sell Now |
| May 8, 2025 | Sell | TCMD | Sheri Louise Dodd | Chief Executive Officer | 3,149 | $9.83 | $648.3M | -23.91% | +205.26% | $31.0K | -1.71% | — | Sell Now |
| Feb 25, 2025 | Sell | TCMD | Elaine M. Birkemeyer | Chief Financial Officer | 2,066 | $14.51 | $648.3M | -23.91% | +205.26% | $30.0K | -1.98% | 10b5-1 | Sell Now |
| Feb 25, 2025 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 6,468 | $14.40 | $648.3M | -23.91% | +205.26% | $93.2K | -7.70% | — | Sell Now |
| Feb 24, 2025 | Sell | TCMD | Elaine M. Birkemeyer | Chief Financial Officer | 3,778 | $14.70 | $648.3M | -23.91% | +205.26% | $55.5K | -3.50% | 10b5-1 | Sell Now |
| Feb 24, 2025 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 4,830 | $14.65 | $648.3M | -23.91% | +205.26% | $70.8K | -5.44% | — | Sell Now |
| Aug 12, 2024 | Sell | TCMD | Sherri Lee Ferstler | Senior VP, Sales | 1,550 | $13.07 | $648.3M | -23.91% | +205.26% | $20.3K | -3.84% | — | Sell Now |
| May 16, 2024 | Sell | TCMD | Elaine M. Birkemeyer | Chief Financial Officer | 3,041 | $13.68 | $648.3M | -23.91% | +205.26% | $41.6K | -4.73% | — | Sell Now |
| May 6, 2024 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 815 | $14.37 | $648.3M | -23.91% | +205.26% | $11.7K | -1.29% | — | Sell Now |
| Feb 27, 2024 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 1,334 | $15.52 | $648.3M | -23.91% | +205.26% | $20.7K | -1.04% | — | Sell Now |
| Feb 27, 2024 | Sell | TCMD | Daniel L. Reuvers | President and CEO | 6,085 | $15.52 | $648.3M | -23.91% | +205.26% | $94.4K | -1.26% | — | Sell Now |
| Feb 23, 2024 | Sell | TCMD | Kristie Burns | Sr. VP Mktg & Clinical Affairs | 4,264 | $15.32 | $648.3M | -23.91% | +205.26% | $65.3K | -3.51% | — | Sell Now |
| Feb 23, 2024 | Sell | TCMD | Daniel L. Reuvers | President and CEO | 11,617 | $15.37 | $648.3M | -23.91% | +205.26% | $178.5K | -2.59% | — | Sell Now |
| Aug 7, 2023 | Sell | TCMD | Daniel L. Reuvers | President and CEO | 1,062 | $20.53 | $648.3M | -23.91% | +205.26% | $21.8K | -0.84% | — | Sell Now |